Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microbial Nutrition01:28

Microbial Nutrition

122
Organisms exhibit remarkable metabolic diversity, categorized based on how they acquire energy and carbon. These strategies enable survival in various ecological niches and are essential for maintaining energy flow and nutrient cycling within ecosystems.Energy and Carbon SourcesOrganisms are classified as phototrophs or chemotrophs based on energy acquisition. Phototrophs use light as their energy source, while chemotrophs rely on oxidizing chemical compounds. Further differentiation arises...
122
Biosynthesis in Bacteria01:24

Biosynthesis in Bacteria

42
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
42
Stringent Response in E. coli01:23

Stringent Response in E. coli

32
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
32
Transduction01:16

Transduction

49
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
49
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

51
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
51
Chemotaxis in E. coli01:27

Chemotaxis in E. coli

42
Chemotaxis in Escherichia coli is a sensory-driven motility mechanism that enables bacteria to navigate chemical gradients, moving toward beneficial environments while avoiding harmful conditions. This process relies on a signal transduction system integrating external chemical cues with flagellar motor control.Chemoreceptors and Signal DetectionE. coli detects chemical gradients through methyl-accepting chemotaxis proteins (MCPs), which are membrane-bound chemoreceptors that sense attractants...
42

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Klebsiella genus as driver of human disease: from infections to non-communicable disorders.

Nature reviews. Microbiology·2026
Same author

Next-generation probiotics: an outlook into current applications and future developments.

Nature reviews. Microbiology·2026
Same author

Maternal antibodies regulate the establishment of murine oral and salivary mucosal immunity.

Nature communications·2026
Same author

Advances and opportunities in measuring dietary intake: from omics to AI.

Nature metabolism·2026
Same author

Human immunodeficiency virus-associated gut microbiome impacts systemic immunodeficiency and susceptibility to opportunistic gut infection.

Nature microbiology·2026
Same author

The gut microbiome connects nutrition and human health.

Nature reviews. Gastroenterology & hepatology·2025
Same journal

RyR1 Calcium Leak and Mitochondrial Ca<sup>2+</sup> Homeostasis in Skeletal Muscle.

Acta physiologica (Oxford, England)·2026
Same journal

Functional Differences in Electrolyte Transport Between the Mouse Proximal and Distal Trachea.

Acta physiologica (Oxford, England)·2026
Same journal

Of Mice and Men: Toward Mouse-Specific Diastolic Echocardiography.

Acta physiologica (Oxford, England)·2026
Same journal

Myosin Post-Translational Modifications Associated With Critical Illness Myopathy.

Acta physiologica (Oxford, England)·2026
Same journal

Phenylalanine Versus Tyrosine (Pos. 367/332 in MCT1/MCT4) in the Substrate Binding Site Defines Affinity and Preferred Directionality of Human Monocarboxylate Transporters 1-4.

Acta physiologica (Oxford, England)·2026
Same journal

Aberrant Potassium Handling by Astrocytes and Epileptic Seizures: A Synthetic Update.

Acta physiologica (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Jul 29, 2025

Monitoring Intraspecies Competition in a Bacterial Cell Population by Cocultivation of Fluorescently Labelled Strains
06:45

Monitoring Intraspecies Competition in a Bacterial Cell Population by Cocultivation of Fluorescently Labelled Strains

Published on: January 18, 2014

8.6K

Engineering bacteria to modulate host metabolism.

Dragos Ciocan1,2, Eran Elinav1,3

  • 1Systems Immunology Department, Weisman Institute of Science, Rehovot, Israel.

Acta Physiologica (Oxford, England)
|May 24, 2023
PubMed
Summary
This summary is machine-generated.

Engineered bacteria offer a novel therapeutic approach to modulate the gut microbiota for treating metabolic disorders. This review explores recent advancements and challenges in using these engineered microbes for metabolic disease management.

Keywords:
engineered bacteriametabolic diseasessynthetic biologysynthetic live therapy

More Related Videos

Using Coculture to Detect Chemically Mediated Interspecies Interactions
08:29

Using Coculture to Detect Chemically Mediated Interspecies Interactions

Published on: October 31, 2013

13.6K
Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon
15:28

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon

Published on: November 16, 2012

14.6K

Related Experiment Videos

Last Updated: Jul 29, 2025

Monitoring Intraspecies Competition in a Bacterial Cell Population by Cocultivation of Fluorescently Labelled Strains
06:45

Monitoring Intraspecies Competition in a Bacterial Cell Population by Cocultivation of Fluorescently Labelled Strains

Published on: January 18, 2014

8.6K
Using Coculture to Detect Chemically Mediated Interspecies Interactions
08:29

Using Coculture to Detect Chemically Mediated Interspecies Interactions

Published on: October 31, 2013

13.6K
Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon
15:28

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon

Published on: November 16, 2012

14.6K

Area of Science:

  • Microbiology
  • Metabolic disorders
  • Synthetic biology

Background:

  • The gut microbiota plays a crucial role in host metabolism and disease.
  • Microbial dysbiosis can contribute to metabolic disease development and progression.
  • Therapeutic strategies targeting the gut microbiota are under active development.

Purpose of the Study:

  • To review the use of engineered bacteria for modulating the gut microbiota.
  • To focus on the application of engineered bacteria in treating metabolic disorders.
  • To discuss recent developments and challenges in this therapeutic area.

Main Methods:

  • Review of current literature on engineered bacteria and gut microbiota.
  • Analysis of therapeutic strategies targeting metabolic disorders via microbiota modulation.
  • Emphasis on engineered bacterial strains for metabolic disease treatment.

Main Results:

  • Engineered bacteria represent a promising strategy for microbiota-based therapies.
  • Significant progress has been made in developing engineered bacterial strains.
  • Challenges remain in optimizing efficacy, safety, and delivery for clinical application.

Conclusions:

  • Engineered bacteria hold potential for treating metabolic disorders by manipulating the gut microbiota.
  • Further research is needed to overcome current challenges and translate this technology into effective clinical treatments.
  • This approach offers a novel avenue for managing complex metabolic diseases.